PAP Cuts Hospitalizations by Nearly a Third in COMISA Patients
ResMed research presented at SLEEP 2024 offered insights into the impact of PAP therapy on patients with COMISA.
Stay updated with breaking news from Adam Benjafield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ResMed research presented at SLEEP 2024 offered insights into the impact of PAP therapy on patients with COMISA.
Expert speakers at the American Thoracic Society (ATS) 2024 international conference share their favorite parts of the event and the key takeaways they will leave the conference with.
In research presented at the American Thoracic Society 2024 International Conference, Benjafield and colleagues explored the treatment of sleep-disordered breathing with adaptive sero-ventilation (ASV) in opioid users with central sleep apnea (CSA).
The survival rate gap remained significant when accounting for patients’ ages, overall health, other pre-existing conditions, and causes of death.